Analystreport

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $160.00 price target on the stock.

Jazz Pharmaceuticals plc - Ordinary Shares  (JAZZ) 
Last jazz pharmaceuticals plc - ordinary shares earnings: 2/25 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: jazzpharma.com